In addition, the authors also identified higher levels of TLR2 mRNA in the MDS group when compared to other hematological neoplasms, such as CLL and multiple myeloma, despite no difference being noted in comparison to AML. This evidence concerns the gene TLR2 and B-cell chronic lymphocytic leukemia.